Insilico Medicine unveils 'Longevity Vaccines' combining AI and circular mRNA
rand_longevity · x · 2026-09-17
AI drug discovery company Insilico Medicine announced its 'Longevity Vaccines' research initiative. Building on its Rentosertib program, the effort extends its strategy of treating disease and biological aging into preventive cell clearing: combining AI and circular mRNA to arm the body's own T cells to remove selected aging immune cells.
More from Research
- DeepMind paper: Veo 3 shows emergent zero-shot reasoning, video models may become vision foundation models — RexDouglass · 2026-09-17
- GoBench: LLMs hit 2500 Elo on 9x9 Go vs KataGo's 4400, r=0.83 with ARC-AGI 2 — Roland31415 · 2026-09-17
- A JSON classifier got 12M views: Niels Rogge visualizes how Jev skips autoregressive generation — rickasaurus · 2026-09-17
- Stanford 2026 AI Index: only half of schools have AI policies, 6% of teachers call them clear — StanfordHAI · 2026-09-17
- AI Researchers Once Put 50% Odds on AI Solving a Millennium Prize Problem by 2054 — Distinct-Question-16 · 2026-09-17
- Scaling Trust Arena Shares Update, Teams with Andon Labs, Publishes Draft Spec — sebkrier · 2026-09-17